ASTC Overview

New CFO Appointment: Astrotech Corporation has appointed Scott Bartley as Interim Chief Financial Officer, effective October 20, 2025, bringing over 20 years of financial expertise to the role.

Background of Scott Bartley: Bartley has extensive experience as a financial consultant and has held CFO positions in various companies, including Westlake Securities and Deloitte & Touche, and is a Certified Public Accountant.

Astrotech's Business Focus: Astrotech operates through subsidiaries that specialize in mass spectrometry and related technologies, serving markets such as security, agriculture, industrial manufacturing, and health diagnostics.

Forward-Looking Statements: The press release includes forward-looking statements that are subject to various risks and uncertainties, emphasizing the potential impact of economic conditions and regulatory changes on the company's future performance.

Financial Loss: Astrotech Corp. reported a full-year loss of -$13.85 million, or -$8.32 per share, compared to a loss of -$11.67 million, or -$7.12 per share, the previous year.

Revenue Decline: The company's revenue decreased by 36.7% to $1.05 million from $1.66 million in the prior year.

Financial Performance: Astrotech Corporation reported a revenue decrease to $1.0 million for the fiscal year ending June 30, 2025, while gross margin slightly increased to 45.3%. The company also recorded a net loss of $13.85 million, compared to a loss of $11.67 million in the previous year.

New Subsidiary and Product Launch: Astrotech formed a new subsidiary, EN-SCAN, Inc., to manufacture environmental testing instruments, and launched the enhanced TRACER 1000 Narcotics Trace Detector, expanding its market presence in security and narcotics screening.

International Expansion: The TRACER 1000 has been deployed in 34 locations across 16 countries, with its first sale in Vietnam marking a significant step in expanding Astrotech's footprint in Southeast Asia.

Future Outlook: The company aims to leverage its mass spectrometry and gas chromatography technologies to meet industry demands, with a focus on organic growth and research and development supported by $18.2 million in cash and liquid investments.

Appointment of COO: Astrotech Corporation has appointed Nihanth Badugu as Chief Operating Officer, effective August 13, 2025, following his successful tenure as Director of Program Management since 2023.

Background and Experience: Mr. Badugu, age 37, has a strong background in program management and operational leadership, previously working at Thermo Fisher Scientific and PVA Consulting Group, contributing to significant projects including COVID-19 diagnostic products.

Company Overview: Astrotech Corporation specializes in mass spectrometry and operates several subsidiaries focused on various applications, including security screening, agriculture, industrial manufacturing, and health diagnostics.

Forward-Looking Statements: The press release includes forward-looking statements that are subject to risks and uncertainties, emphasizing the importance of evaluating these statements in light of potential market and regulatory challenges.